Inovio Pharmaceuticals Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Inovio Pharmaceuticals stock have an average target of 4.25, with a low estimate of 2.50 and a high estimate of 6.00. The average target predicts an increase of 286.36% from the current stock price of 1.10.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.50	$4.25	$6.00	$6.00
Change	+127.27%	+286.36%	+445.45%	+445.45%

Analyst Ratings

The average analyst rating for Inovio Pharmaceuticals stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	1
Buy	2	2	2	2	1	1
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	5	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Hold Reiterates $2.5	Hold	Reiterates	$2.5	+127.27%	Jun 1, 2026
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Reiterates $6	Buy	Reiterates	$6	+445.45%	May 22, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

10.88M

from 65.34K

16,551.75%

from 65.34K

Revenue Next Year

69.07M

from 10.88M

534.83%

from 10.88M

EPS This Year

-1.14

from -1.82

EPS Next Year

-0.41

from -1.14

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.77M	10.26M	832.01K	217.76K	65.34K	10.88M	69.07M
Revenue Growth	-76.05%	478.24%	-91.89%	-73.83%	-69.99%	16,551.75%	534.83%
EPS	-17.45	-14.07	-6.09	-3.95	-1.81	-0.89	-0.39
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	41.5M	122.4M
Avg	10.9M	69.1M
Low	n/a	10.4M

Revenue Growth

Revenue Growth	2026	2027
High	63,446.2%	1,024.7%
Avg	16,551.7%	534.8%
Low	-100.0%	-4.4%

EPS Forecast

EPS	2026	2027
High	-1.01	-0.03
Avg	-1.14	-0.41
Low	-1.27	-0.96

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.